GLA:D Program
GLA:D Program for Hip & Knee Osteo-Arthritis
What is the GLA:D Program?
SPINEgroup is certifed to offer the Hip and Knee OA program from the internationally renowned GLA:D.
GLA:D for Hip and Knee OsteoArthritis is delivered both individual sessions or in a group setting with individualized therapy for hip and knee osteoarthritis for all ages. The GLA:D program is delivered one to one or as a small group 2 times weekly over a 8 week period. There is also 2 group educational sessions to augment your understanding of Osteoarthritis and lifestyle influences over your condition. Cost of the program is covered through your health insurance plans.
Note: For group sessions, the GLA:D program will be conducted virtually through video conferencing. Please contact the clinic for more information. Individual sessions are in person.
Eligibility for Program:
Patients must be at least 10-12 weeks post hip/knee surgical replacement and/or have a medical diagnosis of a hip/knee Osteo-arthritis (OA) or hip or knee injury. Referral from your medical physician is required.
The new GLA:D program will be held on Wednesdays and Fridays for individual sessions and group sessions held during evening hours.
Cost:
Individual (one to one) Sessions: 120 dollars per session (discounts applpied for seniors at 100 dollars) (sessions are 1 hour long)
Group Sessions: 40 dollars per session ($40 x 16) plus cost of initial assessment (160 dollars). Sessions include 2 educational sessions (group) plus 14 rehab sessions (group). (Session are 1 hour) Total cost is $800.
*Note that initial assessment costs will be waived for current/active private or OHIP patients who have recently received an assessment for their hip or knee pain/injury.
Hip and Knee Osteoarthritis: Facts:
20.4% of Canadian adults have arthritis, the vast majority being osteoarthritis (OA). OA can be caused and/or influenced by irreversible factors such as age, sex and heredity, and modifiable factors such as previous joint damage, being overweight, heavy work and weak muscles. Typically, the disease develops slowly over many years and affects articular structures like the joint capsule, menisci and ligaments. The final stage of OA is consistent with articular cartilage loss and changes in the underlying bone, for example bone marrow lesions. The knee and hip joints are most often affected and represent the largest clinical population.
Clinical guidelines for the treatment of knee and hip OA recommend patient education, exercise and weight loss (if needed) as first line treatment. However, clinical practice does not follow the international and national recommendations of early, multimodal, non- operative treatment that includes patient education, exercise and weight loss (if necessary) in patients with OA of the knees or hips before referral to an orthopedic surgeon. Good Life with OA in Denmark (GLA:D®) represents a nationwide evidence-based initiative that follows the current recommendations for the treatment of knee and hip OA. GLA:D® includes patient education and a neuromuscular exercise program conducted twice a week for eight weeks. The associated GLA:D® registry allows monitoring of participants with OA of the knee and hip from symptom onset, through treatment effects and follow-up. The GLA:D® program is currently being implemented in Canada under the tile GLA:D TM Canada.